Rhoen Klinikum AG (WBO:RHK) EBIT: €55 Mil (TTM As of Mar. 2026)


WBO:RHK Rhoen Klinikum AG WBO:RHK
74 GF Score
Price €14.10
GF Value €13.49
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG EBIT?

Rhoen Klinikum AG WBO:RHK +0.71% 74 EBIT is €55 Mil as of Mar. 2026. GuruFocus rates WBO:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.49. The stock has 3 warning signs investors should review.

Rhoen Klinikum AG's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €17 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €55 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Rhoen Klinikum AG's annualized ROC % for the quarter that ended in Mar. 2026 was 4.05%. Rhoen Klinikum AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.10%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Rhoen Klinikum AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.36%.


Rhoen Klinikum AG  (WBO:RHK) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Rhoen Klinikum AG's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=64.548 * ( 1 - 19.32% )/( (1375.586 + 1196.278)/ 2 )
=52.0773264/1285.932
=4.05 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1819.176 - 101.137 - ( 342.453 - max(0, 341.828 - 890.45+342.453))
=1375.586

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1841.057 - 85.213 - ( 578.258 - max(0, 355.558 - 915.124+578.258))
=1196.278

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Rhoen Klinikum AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=68.024/( ( (749.5 + max(5.4690000000001, 0)) + (739.83 + max(-18.692, 0)) )/ 2 )
=68.024/( ( 754.969 + 739.83 )/ 2 )
=68.024/747.3995
=9.10 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(277.502 + 40.578 + 25.117) - (101.137 + 0 + 236.591)
=5.4690000000001

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(257.125 + 42.776 + 36.965) - (85.213 + 0 + 270.345)
=-18.692

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Rhoen Klinikum AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=55.092/748.346
=7.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhoen Klinikum AG EBIT Related Terms


Rhoen Klinikum AG EBIT Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG EBIT Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.56 37.73 51.43 59.60 48.15

Rhoen Klinikum AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.06 10.99 11.85 15.25 17.01

WBO:RHK vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's EV-to-EBIT falls into.


WBO:RHK
74GF Score
Rhoen Klinikum AG WBO:RHK
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €55 Mil mean?
Rhoen Klinikum AG (WBO:RHK) has a EBIT of €55 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Rhoen Klinikum AG.
Is Rhoen Klinikum AG's EBIT too high?
Rhoen Klinikum AG's current EBIT is €55 Mil. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's EBIT compare to HCA and THC?
Rhoen Klinikum AG's EBIT of €55 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Rhoen Klinikum AG. Rhoen Klinikum AG's current EBIT is €55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current EBIT of €55 Mil. The stock's GF Value™ is €13.49, compared to a current price of €14.10 — trading 4.5% above its estimated fair value. The current EBIT is €55 Mil. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current EBIT is €55 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued. The current stock price of €14.10 is trading 4.5% above its estimated GF Value™ of €13.49.

Key valuation signals for WBO:RHK:

  • EBIT: €55 Mil
  • GF Value™: €13.49 vs. price of €14.10 (4.5% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score

Get the complete analysis for WBO:RHK

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.10
Price
€13.49
GF Value